Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anil Ranawat

Orthopaedic Surgery New York, NY Medical Doctor

NPI 1568653947 CMS profile 161525

535 E 70Th St, New York, NY 10021

Open in the dashboard

General payments

$469,494

357 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$27,064

1 holding reported · through program year 2025

Research they led as principal investigator

$72,019 paid to institutions, not to them · program years 2020–2022

Through program year 2025, Anil Ranawat of New York, NY is reported in the CMS Open Payments database as having received $469,494 across 357 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $72,019 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $27,064 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $108,720 60
2024 General $62,797 47
2023 General $73,774 76
2022 General $62,645 44
2021 General $43,367 32
2020 General $42,831 22
2019 General $75,360 76
2025 Ownership $27,064 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anil Ranawat
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Anil Ranawat were reported at $108,720. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Anil Ranawat Orthopaedic Surgery median Middle half National median
2019 $75,360 $644 $140–$2,844 $163
2020 $42,831 $312 $75–$1,860 $114
2021 $43,367 $520 $117–$2,495 $132
2022 $62,645 $598 $128–$2,731 $149
2023 $73,774 $461 $128–$2,264 $160
2024 $62,797 $497 $134–$2,475 $164
2025 $108,720 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $285,282 244 payments
  2. Bodycad USA Corp $79,515 37 payments
  3. Ranfac Corporation $31,075 6 payments
  4. Arthrex, Inc. $21,745 11 payments
  5. Anika Therapeutics, Inc. $19,924 14 payments
  6. Globus Medical, Inc. $10,031 4 payments
  7. Stryker Corporation $7,704 11 payments
  8. Linvatec Corporation $6,965 11 payments
  9. Gotham Surgical Solutions & Devices, Inc. $3,739 1 payment
  10. Xiros Inc $1,304 4 payments
  11. Other $2,210 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $273,425 108 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $143,768 34 payments
  3. Travel and Lodging $28,604 69 payments
  4. Food and Beverage $12,865 141 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $7,075 3 payments
  6. Education $3,739 1 payment
  7. Entertainment $19 1 payment
Products named General payments · program years 2019–2025
  1. Bone Anchors with Arthroscopic Delivery System $67,876 40 payments
  2. SPATIAL FRAME $42,175 17 payments
  3. Bioinductive Implant with Arthroscopic Delivery System - Medium $41,293 24 payments
  4. Fine Osteotomy Osteotomy $38,177 20 payments
  5. HEALICOIL Sports Med Hip $31,690 20 payments
  6. Fine osteotomy Orthopedic $27,390 11 payments
  7. HEALICOIL Sports Med Shoulder $23,863 14 payments
  8. Tactoset $17,124 13 payments
  9. Q-FIX $17,104 6 payments
  10. CAP-FIX $14,024 12 payments
  11. Other $293,438 325 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$77,302

Of which drugs: $7,799

Medicare patients

173

Average age 71

Services billed

755

96 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 58%
Ischemic heart disease 31%
Diabetes 19%
Osteoporosis 19%
Depression 15%
Atrial fibrillation 13%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 17 68 $48

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

357 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record